Value of Ki67 immunostain in identification of malignancy in serous effusions

Diagnostic Cytopathology

Volumn 20, Issue 1, 1999, Pages 24-28

  Saleh, Husain ^a,b,c   Bober, Paula ^b   Tabaczka, Pamela ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DETROIT MEDICAL CENTER   (United States)

^c SINAI GRACE HOSPITAL   (United States)

Author keywords

Immunocytochemistry; Ki67 nuclear antigen; Proliferative cell markers; Serous effusions

Indexed keywords

AVIDIN; BIOTIN; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTODIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PERITONEUM EXUDATE; PLEURA EFFUSION; PRIORITY JOURNAL; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOMA; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CYTODIAGNOSIS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASMS; PERICARDIAL EFFUSION; PLEURAL EFFUSION; SENSITIVITY AND SPECIFICITY;

EID: 0032943951     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0339(199901)20:1<24::AID-DC6>3.0.CO;2-Q     Document Type: Article

References (30)

1. Bottles K, Reznicek MJ, Holly EA, Ahn DK, Layfield LJ, Cohen MB. Cytologic criteria used to diagnose adenocarcinoma in pleural effusions. Mod Pathol 1991;4:677-681.
2. Price PA, Ehya H, Lee JH. Significance of pericellular lacunae in cell blocks of effusions. Acta Cytol 1992;36:333-337.
3. DiBonito L, Falconieri G, Colautti I, Bonifacio D, Dudine S. The positive pleural effusions: a retrospective study of cytopathologic diagnoses with autopsy confirmation. Acta Cytol 1992;36:329-332.
4. Dieterich M, Goodman SN, Rojas-Corona R, Emralino AB, Jimenez-Joseph D, Sherman M. Multivariate analysis of prognostic features in malignant pleural effusions from breast cancer patients. Acta Cytol 1994;38:945-952
5. Venrick MG, Sidawy MK. Cytologic evaluation of serous effusions: processing techniques and optimal number of smears for routine preparation. Am J Clin Pathol 1993;99:182-186.
6. Esteban JM, Yokota S, Husain S, Battifora H. Immunocytochemical profile of benign and carcinomatous effusions: practical approach to difficult diagnosis. Am J Clin Pathol 1990;94:698-705.
7. Rosen-Levin E, Patil JR, Watson CW, Jagirdar J. Distinguishing benign from malignant pleural effusions by lectin immunocytochemistry. Acta Cytol 1989;33:499-504.
8. Nance KV, Silverman JF. Immunocytochemical panel for the identification of malignant cells in serous effusions. Am J Clin Pathol 1991;95: 867-874.
9. Athanassiadou P, Athanassiades P. Lazaris D, Kyrkou K, Petrakakou E, Aravantinos D. Immunocytochemical differentiation of reactive mesothelial cells and adenocarcinoma cells in serous effusions with the use of carcinoembryonic antigen and fibronectin. Acta Cytol 1994;38:718-722.
10. Nance KV, Silverman JF. The utility of ancillary techniques in effusion cytology. Diagn Cytopathol 1992;8:185-189.
11. Mezger J, Stotger O, Schilli G, Bauer S, Wilmanns W. Identification of carcinoma cells in ascitic and pleural fluid: comparison of four panepithelial antigens with carcinoembryonic antigens. Acta Cytol 1992;36:75-81.
12. Jensen ML, Johansen P. Immunocytochemical staining of smears and corresponding cell blocks from serous effusions: a follow-up and comparative investigation. Diagn Cytopathol 1996;15:33-36.
13. Sahin AA, Ro JY, Brown RW, et al. Assessment of Ki67-derived tumor proliferative activity in colorectal adenocarcinoma. Mod Pathol 1994;7: 17-22.
14. Esteban JM, Sheibani K. DNA ploidy analysis of pleural mesotheliomas: its usefulness for their distinction from lung adenocarcinoma. Mod Pathol 1992;5:626-631.
15. El-Habashi AH, Freeman SM, EL-Morsi B, EL-Didi M, Martin A, Marrogi AJ. DNA ploidy and proliferating cell nuclear antigen image analysis of peritoneal and pleural effusions: a possible diagnostic role. Acta Cytol 1997;41:636-648.
16. Matter-Walstra KW, Kraft R. Atypical cells in effusions: diagnostic value of cell image analysis combined with immunocytochemistry. Diagn Cytopathol 1996;15:263-269.
17. Gerdes J, Li L, Schlueter C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki67. Am J Pathol 1991;138:867-873.
18. Linden MD, Ma CK, Kubus J, Brown R, Zarbo RJ. Ki67 and proliferating cell nuclear antigen tumor proliferative induces in DNA diploid colorectal adenocarcinomas. Correlation with histopathologic characteristics and cell cycle analysis with two-color DNA flow cytometry. Am J Clin Pathol 1993;100:206-212.
19. Dalquen P, Baschiera B, Chaffard R. et al. MIBI (Ki67) immunostaining of breast cancer cells in cytology smears. Acta Cytol 1997;41:229-237.
20. Pelosi G, Bresaola E, Manfrin E, Rodella S, Schiavon I, Iannucci A. Immunocytochemical detection of cell proliferation-related antigens in cytologic smears of human malignant neoplasms using PC10, reactive with proliferating cell nuclear antigen, and Ki67. A comparative study. Arch Pathol Lab Med 1994;118:510-518.
21. Porschen R, Lohe B, Hengels K, Borchard F. Assessment of cell proliferation in colorectal carcinomas using the monoclonal antibody Ki67: correlation with pathohistologic criteria and influence of irradiation. Cancer 1989;64:2501-2505.
22. Isola JJ, Helin H, Helle M, Kallioniemi O. Evaluation of cell proliferation in breast carcinoma: comparison of Ki67 immunohistochemical study, DNA flow cytometric analysis and mitotic count. Cancer 1990;65:1180-1184.
23. Popov Z, Hoznek A, Colombel M, et al. The prognostic value of p53 nuclear overexpression and MIB1 as a proliferative marker in transitional cell carcinoma of the bladder. Cancer 1997;80:1472-1481.
24. Wintzer H, Zipfel I, Schulte-Monting J, Hellerich U, von Kleist S. Ki67 immunostaining in human breast tumor and its relationship to prognosis. Cancer 1991;67:421-428.
25. Mulder AH, Hootegem SP, Sylvester R, et al. Prognostic factors in bladder carcinoma: histologic parameters and expression of a cell cycle-related nuclear antigen (Ki-67). J Pathol 1992;166:37-43.
26. Gerdes J. Ki67 and other proliferation markers useful for immunohistochemical diagnostic and prognostic evaluations in human malignancies. Cancer Biol 1990;1:199-206.
27. Ishida H, Irie K, Itoth T, Furukawa T, Tokunaga O. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki67 growth fraction. Cancer 1997;80:1034-1045.
28. Hitchcock C. Ki67 staining as a means to simplify analysis of tumor cell proliferation (editorial). Am J Clin Pathol 1991;96:444-446.
29. Suthipintawong C, Leong A, Chan K, Vinyuvat S. Immunostaining of estrogen receptor, progesterone receptor, MIB1 antigen, and c-erbB-2 oncoprotein in cytologic specimens: a simplified method with formalin fixation. Diagn Cytopathol 1997;17:127-133.
30. Bozzetti C, Nizzoli R, Camisa R, et al. Comparison between Ki-67 index and S-phase fraction on fine needle aspiration samples from breast carcinoma. Cancer (Cancer Cytopathol) 1997;81:287-292.